发明名称 |
Modified cell lines for increasing lentiviral titers |
摘要 |
The present disclosure provides a method of modifying cells in order to enhance lentiviral titers, cell lines that are modified and modifying reagents. By mediating individual genes and combination thereof, lentiviral titers may be increased. |
申请公布号 |
US9284552(B2) |
申请公布日期 |
2016.03.15 |
申请号 |
US201313854995 |
申请日期 |
2013.04.02 |
申请人 |
GE Healthcare Dharmacon, Inc. |
发明人 |
Spayd Katie Jansen;Karpilow Jon;Wakefield John K. |
分类号 |
C12N7/01;C12N7/02;C12N15/86;A61K39/21;C12N15/113 |
主分类号 |
C12N7/01 |
代理机构 |
Dorf & Nelson LLP |
代理人 |
Dorf & Nelson LLP ;Locke, Esq. Scott D. |
主权项 |
1. A method of enhancing lentiviral titers comprising modulating expression of a plurality of host genes in a packaging cell, wherein the modulation comprises”
a) suppressing expression of Tetherin, and b) at least one of
i) suppressing expression of at least one of Dicer and DGCR8, andii) increasing expression of at least one of TSG101 and Anx2. |
地址 |
Lafayette CO US |